Project List
List projects.
Fields
id (integer)
Primary key.
Expansions
To activate relation expansion add the desired fields as a comma separated
list to the expand query parameter like this:
?expand=<field>,<field>,<field>,...
The following relational fields can be expanded:
organizationcategorytypepartner_functionmanagercontactstatusgrantresearcheventstudylanguageprogramfunders
Filters
To filter for exact value matches:
?<fieldname>=<value>
Possible exact filters:
organizationcategorymanagercontactstatusgrantresearchstudylanguagefundersprogram
For advanced filtering use lookups:
?<fieldname>__<lookup>=<value>
All fields with advanced lookups can also be used for exact value matches as described above.
Possible advanced lookups:
begin_planned:gt,gte,lt,ltebegin_effective:gt,gte,lt,lteend_planned:gt,gte,lt,lteend_effective:gt,gte,lt,lte
GET /v1/research/project/?format=api&offset=1740&ordering=begin_planned
{ "count": 2329, "next": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=1760&ordering=begin_planned", "previous": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=1720&ordering=begin_planned", "results": [ { "id": 7824, "title": { "de": "ACKR1 und ACKR4 in der experimentellen Glomerulonephritis", "en": "ACKR1 and ACKR4 in experimental kidney diseases" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-11-01T01:00:00+01:00", "begin_effective": "2021-11-01T01:00:00+01:00", "end_planned": "2023-04-30T02:00:00+02:00", "end_effective": "2023-04-30T02:00:00+02:00", "assignment": "2023-10-10T10:23:38+02:00", "program": 69, "subprogram": null, "organization": 14084, "category": 10, "type": 10, "partner_function": 4, "manager": 86588, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "J 4606", "ethics_committee": null, "edudract_number": null, "persons": [ "7824-86588-10" ] }, { "id": 7051, "title": { "de": "Die Welt in 2050", "en": "The World in 2050" }, "short": "World 2050", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-11-01T01:00:00+01:00", "begin_effective": "2022-06-01T02:00:00+02:00", "end_planned": "2022-10-31T01:00:00+01:00", "end_effective": "2024-03-31T01:00:00+01:00", "assignment": "2022-06-09T11:03:37+02:00", "program": null, "subprogram": null, "organization": 23612, "category": 10, "type": 10, "partner_function": 1, "manager": 54033, "contact": null, "status": 2, "research": 5, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": "00000409", "ethics_committee": null, "edudract_number": null, "persons": [ "7051-54033-10" ] }, { "id": 8268, "title": { "de": "Standardisierte elektronische Erfassung der Beschwerden und der Lebensqualität von Patienten/Innen mit Kopf/Hals Karzinom unter laufender Radiochemotherapie", "en": "Standardized electronic symptom and quality of life tracking of patients with head and neck cancer during radiotherapy." }, "short": "QOLHNC", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-11-01T01:00:00+01:00", "begin_effective": "2021-11-01T01:00:00+01:00", "end_planned": "2026-11-01T01:00:00+01:00", "end_effective": "2026-11-01T01:00:00+01:00", "assignment": "2024-06-19T15:15:36+02:00", "program": null, "subprogram": null, "organization": 14066, "category": 10, "type": 10, "partner_function": 3, "manager": 57935, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8268-57935-10" ] }, { "id": 6869, "title": { "de": "Peptidomimetisce INhibitoren für CRAC-Kanal", "en": "Light-activatable peptidomimetic inhibitors for CRAC-channel" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-11-01T01:00:00+01:00", "begin_effective": "2021-11-01T01:00:00+01:00", "end_planned": "2025-10-31T01:00:00+01:00", "end_effective": "2027-01-31T01:00:00+01:00", "assignment": "2022-01-05T15:23:09+01:00", "program": 72, "subprogram": null, "organization": 14011, "category": 10, "type": 10, "partner_function": 4, "manager": 86144, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "I5611", "ethics_committee": null, "edudract_number": null, "persons": [ "6869-86144-10", "6869-116508-12" ] }, { "id": 7236, "title": { "de": "Der Effekt von prä-operativer Flüssigkeitsgabe auf den Blutdruck bei Narkose-Einleitung", "en": "Effect of Pre-operative Intravenous Crystalloids on Post-Induction Blood Pressure\r\n" }, "short": "Preop Fluid Study", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-11-01T01:00:00+01:00", "begin_effective": "2022-12-01T01:00:00+01:00", "end_planned": "2024-06-01T02:00:00+02:00", "end_effective": "2025-11-30T01:00:00+01:00", "assignment": "2022-10-28T17:08:41+02:00", "program": 108, "subprogram": null, "organization": 14069, "category": 10, "type": 10, "partner_function": 4, "manager": 107954, "contact": null, "status": 2, "research": 4, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "KLI 1097", "ethics_committee": null, "edudract_number": null, "persons": [ "7236-95708-11", "7236-97332-12", "7236-100461-12", "7236-107954-10" ] }, { "id": 6778, "title": { "de": "Ist die Zusammensetzung der Membranlipide vom Cix-Dux4 \r\nTranskriptionsfaktorfusionssarkomen im Vergleich zum Ewing \r\nSarkom ein Grund für deren Aggressivität und fehlendem \r\nAnsprechen auf Chemotherapeutika im Sinne einer \r\nResistenzbildung?", "en": "Is the membrane lipid composition of the CIC-DUX4 merged sarcoma in comparison to the Ewing sarcoma one reason for their aggressiveness and missing response to a treatment \r\nfor the purpose of an resistence?" }, "short": "Cix-Dux4", "url": null, "abstract": { "de": "Die beiden Mitglieder der Gruppe der klein rund und blauzelligen Sarkome des Binde und Stützgewebes Ewing und CIC-DUX4 sind sich hinsichtlich ihrer Histologie sehr ähnlich. Betrachtet man jedoch molekulare Gesichtspunkte, Alter der PatientInnen und vor allem das Outcome sind diese sehr heterogen.\r\nEwing Sarkome betreffen vor allem Kinder und Jugendliche. Die 5 Jahres Überlebens Wahrscheinlichkeit beträgt ohne Metastasierung über 70% (S1 Leitlinien Ewing Sarkome des Kindes und Jugendalters, Stand 2014, Antonescu et al. beschreibt sogar 82%). Die derzeitige Behandlung erfolgt mit dem VIDE Schema (Vincristin, Ifosfamid, Doxorubicin, Etoposid).\r\nSeltener, aber bösartiger ist das CIC-DUX4 fusionierte Sarkom. Diese Erkrankung trifft PatientInnen im Median von 31 Jahren. Allerdings sind alle Altersgruppen vertreten. CIC und DUX4 sind zwei Genabschnitte, welche fusioniert sind. Aufgrund der Tatsache, dass CIC-DUX4 und Ewing morphologisch ähnlich sind, werden sie gleich therapiert. Obwohl molekulargenetisch bereits festgestellt ist, dass es sich dabei um verschiedene Entitäten handelt. Mit dem Ergebnis, dass die 5-Jahres-Überlebensrate von Patientinnen mit CIC-DUX4 Sarkom bei 43% (Antonescou et al.) liegt.\r\nZiel dieses Projekts ist es, mögliche Resistenzmechanismen der beiden Sarkomentitäten charakterisieren zu können.\r\nDabei handelt es sich um einen Zellkulturversuch.\r\nEin wesentlicher Faktor zur Resistenz gegenüber Chemotherapeutika ist die Zellmembran. Die Zellmembran besteht aus drei Hauptlipiden: Phospholipiden, Sphingolipiden und Cholesterin. Dabei soll die Lipidzusammensetzung der Zellen mittels Massenspektrometrie analysiert werden.\r\nWeiters werden die Sarkome Ultrastrukturell auf Fett Tröpfchen analysiert. Dies kann einen Hinweis auf Resistenzen geben, denn lipophile Therapeutika (wie zum Beispiel das Doxorubicin) könnten darin gefangen werden und dadurch keinen ausreichenden Wirkspiegel im Zellkern ausbilden.\r\nDie funktionale Bestätigung einer möglichen Resistenzbidldung in CIC-DUX4 Sarkomen durch Lipiddetektion mitels Massenspektrometrie und ultrastruktureller Aufklärung in Bezug auf Fett Tröpfchen soll mittels Compound Testing erfolgen.", "en": null }, "begin_planned": "2021-11-05T01:00:00+01:00", "begin_effective": "2021-11-01T01:00:00+01:00", "end_planned": "2022-07-01T02:00:00+02:00", "end_effective": "2022-11-30T01:00:00+01:00", "assignment": "2021-11-04T14:34:16+01:00", "program": null, "subprogram": null, "organization": 27477, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2471 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 7007, "title": { "de": "Der Einfluss des Harntrakt-Mikrobioms auf ‚Lower Urinary Tract Symptomes’ (LUTS) bei Männern", "en": "The influence of urinary tract microbiome on male lower urinary tract symptomes (LUTS)" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-12-01T01:00:00+01:00", "begin_effective": "2021-12-01T01:00:00+01:00", "end_planned": "2023-12-01T01:00:00+01:00", "end_effective": "2026-12-31T01:00:00+01:00", "assignment": "2022-05-02T10:13:59+02:00", "program": null, "subprogram": null, "organization": 14056, "category": 10, "type": 10, "partner_function": 4, "manager": 113095, "contact": null, "status": 2, "research": 5, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2471 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "7007-113095-10" ] }, { "id": 6818, "title": { "de": "Isoflavonmessung, Mikrobiom und endokrine Characterisierung", "en": "Isoflavone measurement, microbiome and endocrine characterisation" }, "short": "IsoMiEndo", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-12-01T01:00:00+01:00", "begin_effective": "2021-12-01T01:00:00+01:00", "end_planned": "2022-12-01T01:00:00+01:00", "end_effective": "2022-12-01T01:00:00+01:00", "assignment": "2021-12-07T17:55:45+01:00", "program": null, "subprogram": null, "organization": 14080, "category": 10, "type": 10, "partner_function": 4, "manager": 51809, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-67", "ethics_committee": null, "edudract_number": null, "persons": [ "6818-51809-10", "6818-109041-12" ] }, { "id": 6949, "title": { "de": "Alterungsforschung im Fadenwurm", "en": "Aging research in Caenorhabditis elegans" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-12-01T01:00:00+01:00", "begin_effective": "2021-12-01T01:00:00+01:00", "end_planned": "2022-11-30T01:00:00+01:00", "end_effective": "2022-11-30T01:00:00+01:00", "assignment": "2022-03-07T14:22:38+01:00", "program": null, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 85069, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6949-85069-10" ] }, { "id": 6881, "title": { "de": "Biomarker für kardiovaskuläre Risiken und neurodegenerative Erkrankungen nach insulininduzierter Hypoglykämie", "en": "Biomarkers for cardiovascular risk and neurodegenerative disease following insulin-induced hypoglycaemia" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-12-01T01:00:00+01:00", "begin_effective": "2021-12-01T01:00:00+01:00", "end_planned": "2022-06-30T02:00:00+02:00", "end_effective": "2022-06-30T02:00:00+02:00", "assignment": "2022-01-17T15:13:04+01:00", "program": null, "subprogram": null, "organization": 14080, "category": 10, "type": 10, "partner_function": 1, "manager": 100944, "contact": null, "status": 2, "research": 4, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 151 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6881-78894-11", "6881-100944-10" ] }, { "id": 6852, "title": { "de": "Anomalien im Fettstoffwechsel von PEMT-Knockout Mäusen", "en": "Abnormalities in lipid metabolism of PEMT knockout mice." }, "short": "PEMT-KO-Mäuse", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2021-12-17T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2023-04-30T02:00:00+02:00", "end_effective": "2026-03-31T02:00:00+02:00", "assignment": "2021-12-20T09:49:08+01:00", "program": null, "subprogram": null, "organization": 14012, "category": 10, "type": 10, "partner_function": 4, "manager": 50712, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 457 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6852-50712-10" ] }, { "id": 7156, "title": { "de": "doc.fund BioMolStruct - Zusatzfinanzierung (2. Förderjahr)", "en": "doc.fund BioMolStruct - Zusatzfinanzierung (2. Förderjahr)" }, "short": "BioMolStruct - ZF", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2022-12-31T01:00:00+01:00", "end_effective": "2022-12-31T01:00:00+01:00", "assignment": "2022-09-05T15:58:43+02:00", "program": null, "subprogram": null, "organization": 14012, "category": 10, "type": 10, "partner_function": 4, "manager": 91207, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2471 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "7156-91207-10" ] }, { "id": 7055, "title": { "de": "Lösung des offenen Rätsels von TRPC3 durch Photopharmakologie", "en": "Resolving the open state enigma of TRPC3 by photopharmacology" }, "short": null, "url": null, "abstract": { "de": "• Wider research context / theoretical framework: TRPC3 is a distinct member of TRPC family. This channel is expressed in excitable and non-excitable cells. By non-selectively conducting cations even at its resting state, TRPC3 promotes cellular processes in both health and disease. However, there are only a few modulators of this channel available. To precisely design new therapeutic ligands, it is of high importance to gain knowledge about TRPC3 protein structure and, consequently, its gating mechanism. Recently, two TRPC3 structures were revealed by cryo electron microscopy (cryo-EM). Nonetheless, neither of them captured open pore architecture. Hence, the open conformations is the critical missing piece of information to solve the TRPC3 gating puzzle. This knowledge is essential for comprehension of the molecular function of TRPC3 and definition of possible ligand binding sites to control this channel is health and, especially, disease.\r\n• Hypotheses / research questions / objectives: Here, we propose to succeed in capturing open pore structures of TRPC3 by stabilizing and synchronizing the channels at a high open probability using photochromic ligands and in addition by preserving their lipid environment during the protein preparation for cryo-EM.\r\n• Approach / methods: We will screen two expression systems for suitability to maintain TRPC3 in open conformation. We will utilize photopharmacological tools for a temporal control over TRPC3 gating during protein extraction and cryo-EM. Structural details obtained from cryo-EM will be followed by structure-guided mutagenesis and evaluated in a multifunctional live cell approach combining Ca2+ imaging and electrophysiology.\r\n• Level of originality / innovation: With our project, we will introduce a novel approach to control protein conformations during cryo-EM by photoswitchable ligands. Our work will unravel TRPC3 open architecture and promote the development of new concepts for therapeutic targeting of these channels.\r\n• Primary researchers involved: The research team will include profound experts in TRPC3 electrophysiology and Ca2+ signaling Dr. Oleksandra Tiapko and Dr. Klaus Groschner (Medical University of Graz, Austria), experts in membrane lipids Dr. Anita Emmerstorfer-Augustin (Graz University of Technology) and in structural biology and electron microscopy Dr. Christine Ziegler (University of Regensburg).", "en": "• Wider research context / theoretical framework: TRPC3 is a distinct member of TRPC family. This channel is expressed in excitable and non-excitable cells. By non-selectively conducting cations even at its resting state, TRPC3 promotes cellular processes in both health and disease. However, there are only a few modulators of this channel available. To precisely design new therapeutic ligands, it is of high importance to gain knowledge about TRPC3 protein structure and, consequently, its gating mechanism. Recently, two TRPC3 structures were revealed by cryo electron microscopy (cryo-EM). Nonetheless, neither of them captured open pore architecture. Hence, the open conformations is the critical missing piece of information to solve the TRPC3 gating puzzle. This knowledge is essential for comprehension of the molecular function of TRPC3 and definition of possible ligand binding sites to control this channel is health and, especially, disease.\r\n• Hypotheses / research questions / objectives: Here, we propose to succeed in capturing open pore structures of TRPC3 by stabilizing and synchronizing the channels at a high open probability using photochromic ligands and in addition by preserving their lipid environment during the protein preparation for cryo-EM.\r\n• Approach / methods: We will screen two expression systems for suitability to maintain TRPC3 in open conformation. We will utilize photopharmacological tools for a temporal control over TRPC3 gating during protein extraction and cryo-EM. Structural details obtained from cryo-EM will be followed by structure-guided mutagenesis and evaluated in a multifunctional live cell approach combining Ca2+ imaging and electrophysiology.\r\n• Level of originality / innovation: With our project, we will introduce a novel approach to control protein conformations during cryo-EM by photoswitchable ligands. Our work will unravel TRPC3 open architecture and promote the development of new concepts for therapeutic targeting of these channels.\r\n• Primary researchers involved: The research team will include profound experts in TRPC3 electrophysiology and Ca2+ signaling Dr. Oleksandra Tiapko and Dr. Klaus Groschner (Medical University of Graz, Austria), experts in membrane lipids Dr. Anita Emmerstorfer-Augustin (Graz University of Technology) and in structural biology and electron microscopy Dr. Christine Ziegler (University of Regensburg)." }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2025-12-31T01:00:00+01:00", "end_effective": "2026-10-31T01:00:00+01:00", "assignment": "2022-06-13T15:55:42+02:00", "program": 72, "subprogram": null, "organization": 14011, "category": 10, "type": 10, "partner_function": 4, "manager": 90337, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": " P 35291", "ethics_committee": null, "edudract_number": null, "persons": [ "7055-90337-10", "7055-116421-12" ] }, { "id": 7037, "title": { "de": "Innovatives Pilotprojekt: Forschung zur Laserakupunktur und Lasermedizin", "en": "Innovative Pilot Project: Research on Laser Acupuncture and Laser Medicine" }, "short": "Lasermedizin", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2022-12-31T01:00:00+01:00", "end_effective": "2022-12-31T01:00:00+01:00", "assignment": "2022-05-31T11:14:30+02:00", "program": null, "subprogram": null, "organization": 14044, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 762 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 6719, "title": { "de": "Risikopersonen für iatrogene Kiefernekrosen und Knochenbrüche bei Osteoporose- und Krebstherapien frühzeitig identifizieren ", "en": "MRONJ and AFF risk identification and prediction in osteoporosis and cancer patients (RIO)" }, "short": "MEFO-RIO", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2021-11-01T01:00:00+01:00", "end_planned": "2024-12-31T01:00:00+01:00", "end_effective": "2026-12-31T01:00:00+01:00", "assignment": "2021-09-30T15:29:09+02:00", "program": null, "subprogram": null, "organization": 14080, "category": 10, "type": 10, "partner_function": 4, "manager": 98005, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-65", "ethics_committee": null, "edudract_number": null, "persons": [ "6719-50909-12", "6719-98005-10" ] }, { "id": 7183, "title": { "de": "Optimierung des Katheterwechsels bei der Therapie mit Insulinpumpen mittels Messung des Gewebewiderstands", "en": "Optimising the timing of infusion set replacement in insulin pump therapy using tissue flow resistance monitoring" }, "short": "Opt-INFUSE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-09-05T02:00:00+02:00", "end_planned": "2023-12-31T01:00:00+01:00", "end_effective": "2024-09-04T02:00:00+02:00", "assignment": "2022-09-26T16:37:02+02:00", "program": null, "subprogram": null, "organization": 14080, "category": 10, "type": 10, "partner_function": 4, "manager": 51831, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2689 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "7183-51831-10", "7183-50452-12", "7183-103585-12" ] }, { "id": 6942, "title": { "de": "CBmed: MODUL - Mikroplastik: Eine Gefahr für die menschliche Gesundheit Projekt 3\r\nInteraktion - Gesundheitseffekte - Prävention", "en": "CBmed: MODUL - Microplastic Particles: A Hazard for Human Health Project 3\r\nINTERACTION – HUMAN HEALTH EFFECTS – TREATMENT" }, "short": "MicroONE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2025-12-31T01:00:00+01:00", "end_effective": "2026-12-31T01:00:00+01:00", "assignment": "2022-03-02T13:48:50+01:00", "program": 94, "subprogram": null, "organization": 14081, "category": 10, "type": 10, "partner_function": 4, "manager": 50989, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 416 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6942-81091-12", "6942-107131-12", "6942-106674-12", "6942-112689-12", "6942-50989-10", "6942-114553-12", "6942-115621-12", "6942-125874-12", "6942-126494-12", "6942-124112-12" ] }, { "id": 6927, "title": { "de": "Charakterisierung der therapierelevanten epigenetischen Grundlagen des fortgeschrittenen Lungenkarzinom ", "en": "Characterizing the epigenetics of lung cancer progression to inform\r\npersonalized treatment" }, "short": "epiLUAD", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-02-01T01:00:00+01:00", "end_planned": "2023-12-31T01:00:00+01:00", "end_effective": "2026-12-31T01:00:00+01:00", "assignment": "2022-02-15T12:48:51+01:00", "program": null, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": 4, "manager": 109087, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-77", "ethics_committee": null, "edudract_number": null, "persons": [ "6927-109087-10" ] }, { "id": 6928, "title": { "de": "Apoptose als therapeutischer Angriffspunkt bei behandlungsresistentem Lungenkrebs", "en": "Targeting the apoptotic pathway to overcome therapy resistance in lung cancer" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2023-12-31T01:00:00+01:00", "end_effective": "2024-12-31T01:00:00+01:00", "assignment": "2022-02-15T13:14:17+01:00", "program": null, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": 4, "manager": 109002, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-75", "ethics_committee": null, "edudract_number": null, "persons": [ "6928-109002-10" ] }, { "id": 6931, "title": { "de": "Überwindung von Resistenzen in der Krebstherapie - Identifizierung neuer therapeutischer Angriffspunkte mittels dualen CRISPRko und CRISPRa Screens", "en": "Using dual CRISPRko and CRISPRa screens to identify novel\r\ntargets to overcome cancer drug resistance" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2024-12-31T01:00:00+01:00", "end_effective": "2024-12-31T01:00:00+01:00", "assignment": "2022-02-17T11:44:31+01:00", "program": null, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": 4, "manager": 109002, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 894 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6931-98327-12", "6931-109501-12", "6931-109002-10" ] } ] }